209 related articles for article (PubMed ID: 30274043)
1. In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment.
Bischoff I; Tsaryk R; Chai F; Fürst R; Kirkpatrick CJ; Unger RE
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():115-124. PubMed ID: 30274043
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of anticancer efficacy of drug loaded cockle shell-derived aragonite nanoparticles.
Wenliang F; Rameli MABP; Ibrahim TAT; Noor MHM; Yusof LM; Zakaria MZAB
J Biomed Mater Res B Appl Biomater; 2019 Aug; 107(6):1898-1907. PubMed ID: 30597760
[TBL] [Abstract][Full Text] [Related]
3. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
4. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ
J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746
[TBL] [Abstract][Full Text] [Related]
5. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
[TBL] [Abstract][Full Text] [Related]
7. In vitro delivery and controlled release of Doxorubicin for targeting osteosarcoma bone cancer.
Kamba SA; Ismail M; Hussein-Al-Ali SH; Ibrahim TA; Zakaria ZA
Molecules; 2013 Aug; 18(9):10580-98. PubMed ID: 23999729
[TBL] [Abstract][Full Text] [Related]
8. Antitumor efficacy of doxorubicin-loaded laponite/alginate hybrid hydrogels.
Gonçalves M; Figueira P; Maciel D; Rodrigues J; Shi X; Tomás H; Li Y
Macromol Biosci; 2014 Jan; 14(1):110-20. PubMed ID: 23966317
[TBL] [Abstract][Full Text] [Related]
9. Poly-cyclodextrin functionalized porous bioceramics for local chemotherapy and anticancer bone reconstruction.
Chai F; Abdelkarim M; Laurent T; Tabary N; Degoutin S; Simon N; Peters F; Blanchemain N; Martel B; Hildebrand HF
J Biomed Mater Res B Appl Biomater; 2014 Aug; 102(6):1130-9. PubMed ID: 24347296
[TBL] [Abstract][Full Text] [Related]
10. Toward a doxorubicin-loaded bioinspired bone cement for the localized treatment of osteosarcoma.
Martinez T; Sarda S; Dupret-Bories A; Charvillat C; Projetti F; Drouet C
Future Oncol; 2021 Sep; 17(26):3511-3528. PubMed ID: 34213375
[No Abstract] [Full Text] [Related]
11. 12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma.
David E; Cagnol S; Goujon JY; Egorov M; Taurelle J; Benesteau C; Morandeau L; Moal C; Sicard M; Pairel S; Heymann D; Redini F; Gouin F; Le Bot R
Bioconjug Chem; 2019 Jun; 30(6):1665-1676. PubMed ID: 31045351
[TBL] [Abstract][Full Text] [Related]
12.
Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
[No Abstract] [Full Text] [Related]
13. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
[TBL] [Abstract][Full Text] [Related]
14. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin loaded magnetism nanoparticles based on cyclodextrin dendritic-graphene oxide inhibited MCF-7 cell proliferation.
Mihanfar A; Targhazeh N; Sadighparvar S; Darband SG; Majidinia M; Yousefi B
Biomol Concepts; 2021 Apr; 12(1):8-15. PubMed ID: 33878249
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
17. Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma.
Kusuzaki K; Takeshita H; Murata H; Hirata M; Hashiguchi S; Ashihara T; Hirasawa Y
Cancer; 1998 Jun; 82(12):2343-9. PubMed ID: 9635526
[TBL] [Abstract][Full Text] [Related]
18. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
[TBL] [Abstract][Full Text] [Related]
19. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix.
Harisi R; Dudás J; Tímár F; Pogány G; Paku S; Tímár J; Kovalszky I; Szendroi M; Jeney A
Anticancer Res; 2005; 25(2A):805-13. PubMed ID: 15868912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
